In the current study, we found that H53 showed good antagonistic properties in vivo and in vitro, not only inhibiting GHR/PRLR-mediated intracellular signals, but also blocking breast tumor proliferation (Figures 6–12). This evidence concerns the gene PRLR and breast neoplasm.